Google DeepMind’s vice president of science says the lab is witnessing “a genuine phase transition in the pace of scientific discovery” — and that the public will “see a glimpse of this in our releases in the next few weeks.” The statement, posted by Pushmeet Kohli on X on Sunday morning, is a tease, not an announcement: it names no release, no date, and no measure of the acceleration it claims.

That distinction matters, because the post spread fast and the retellings quickly outran the original. Within about an hour, a thread sharing screenshots of Kohli’s posts rose to the top of r/singularity, and reposts on X added their own readings — one calling it a sign that Google DeepMind is “about to shock the entire world.” None of that is in Kohli’s words. What follows is what he actually said, what the community made of it, and what the lab’s recent publishing pattern suggests is coming.

What Kohli actually said#

Kohli’s post, published at 10:15 UTC (5:15 a.m. EST) on November 8, reads in full: “Across our projects @GoogleDeepMind, we are witnessing a genuine phase transition in the pace of scientific discovery. You will see a glimpse of this in our releases in the next few weeks.” A second post the same morning added that “as this AI-powered acceleration unfolds, our focus will be on empowering the broader scientific community to harness these tools responsibly.”

Kohli is DeepMind’s VP of Science and Chief Scientist at Google Cloud, and his profile lists the lab’s science portfolio: AlphaFold, AlphaGenome, AlphaCode, AlphaEvolve, AlphaEarth, AlphaProof, Co-Scientist and SynthID. He was also the messenger for DeepMind’s other announcement this week: on November 6 he shared the lab’s findings on AI agents finding weaknesses in legacy 1024-bit RSA encryption, which we covered on Saturday.

How the internet read it#

The r/singularity thread that carried the screenshots passed 100 upvotes within about an hour, and the guesses in the replies show the range of what “scientific discovery” could mean at DeepMind: a new Co-Scientist release, drug discovery, materials science, an AlphaFold 4, or — the more cynical guess — another benchmark. One commenter suggested the claim must concern highly mathematical problems, since most science needs experiments and verification time.

The skeptics were loud too. Several top comments pushed back by pointing to Isomorphic Labs, DeepMind’s drug-discovery spinout, arguing its slow progress toward clinical trials is a reason to wait for evidence before celebrating. The thread’s prevailing mood was impatience: posters wanted actual releases or breakthroughs rather than an announcement of an announcement. That is a fair reading of a post that promises a glimpse and delivers, for now, only the promise.

AlphaFold 2 results and architecture from the 2021 Nature paper
AlphaFold 2’s CASP14 results and architecture, from Jumper et al., Nature 2021, CC BY 4.0, via Wikimedia Commons. AlphaFold is the best-known example of the science program Kohli oversees.

The recent pattern#

Kohli’s post also lands against a visible publishing rhythm. DeepMind’s blog has carried five Science posts since September 3: WeatherNext 3, AlphaGenome Atlas, SynthID Bio, antimicrobial peptides, and agentic cheminformatics, the latest dated November 3. The gaps between them run 5, 22, 15 and 19 days — a median of 17 — so a post on November 8 comes five days after the latest, well inside the usual cadence. That arithmetic comes from FourWeekMBA’s read of the blog. It cuts both ways: either the next release is imminent, or Kohli is talking up a normal week.

The content of those posts is the more useful clue. The two latest are walkthroughs of Google Antigravity, the company’s agentic development platform, rather than standalone model launches: the October post describes a drug-design lead now undergoing wet-lab validation, and the November post says an agent proposed novel rigidified macrocycles with synthetic routes “in just an hour,” against a workflow that “typically takes multiple days for a single iteration.” If the coming “glimpse” follows the same pattern, expect tools and workflows — science delivered as software — rather than a single headline model.

The Evoformer and structure module at the heart of AlphaFold 2
The Evoformer and structure module at the heart of AlphaFold 2, from Jumper et al., Nature 2021, CC BY 4.0, via Wikimedia Commons.

What to watch#

The test is simple: releases in the next few weeks. Watch whether they arrive as papers, as models, or as Antigravity workflows — and whether they carry measurements, not just adjectives. A “phase transition” is a strong claim about pace; the evidence for it will be in the cadence and the substance of what ships, not in the post itself.

Watch who else picks up the language. Kohli’s framing — pace, not a single result — echoes how DeepMind has talked about its science program all year, from AlphaFold to the agentic chemistry work. If the coming releases are mostly workflow demos, the story is distribution: science tools reaching working researchers through Google’s developer products. If one is a standalone result, the tease will look restrained in hindsight. Either way, the post is on the record now, and the clock Kohli set runs for a few weeks.

Sources: Pushmeet Kohli on X (November 8, 2026), via the screenshots shared on r/singularity and quoted by FourWeekMBA; Jumper et al., “Highly accurate protein structure prediction with AlphaFold”, Nature (2021), for the figures.